We recently reported that the overexpression of the NFκB (p65) super-repressor inhibited GD3S expression in breast cancer cells [6], suggesting that NFκB signaling could be an important regulator in BCSC tumorigenic functions. Here, NFKB1 is linked to breast cancer.